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Introduction {#sec007}
============

Globally, 15 million babies are born preterm every year \[[@pone.0238315.ref001]\]. These babies are difficult to identify at birth, particularly in resource limited settings where gestational age (GA) may not be accurately assessed prenatally by ultrasound (USG) and estimates of the traditionally used method of estimating GA using the first day of her last menstrual period (LMP) may be unreliable. Since preterm babies are at high risk of morbidity and mortality, it is necessary to estimate GA at birth for early referral and management.

The estimation of GA using LMP is dependent on the regularity of the pregnant woman's menstrual cycle, as well as an accurate recall by her of the date of the first day of the last period. It has been reported that this date is uncertain in 20% of pregnant women \[[@pone.0238315.ref002]\]. Theoretically, if a woman enrolls early for prenatal care and has a USG then the early USG can be used for ascertainment of GA, especially if LMP is unreliable. However, women from LMICs usually enroll late for prenatal care and are less likely to remember the date of LMP. Further, there is a paucity of USG availability in these countries and it is not available at rural community health facilities. In facilities where USG is available it is prioritized for women in the third trimester of pregnancy. USG is less predictive of GA when estimated late in pregnancy \[[@pone.0238315.ref003], [@pone.0238315.ref004]\]. Therefore, newborns are often identified as preterm just after birth by community birth attendants at the community health facilities. In such circumstances, accurate and feasible methods of determining postnatal GA by the community birth attendants would help early recognition and facilitate referral of preterm newborns for appropriate management.

Postnatal GA assessment scores such as Dubowitz Score (DS) and New Ballard Score (NBS) have been used widely but are complex and require neurological examination, and may be altered when a newborn has morbidities like birth asphyxia, infection or congenital anomalies. Another limitation is that these scores have not been evaluated for regional, geographical, racial or ethnic robustness. The Meharban Singh scale (MS) was developed in India in 1975. Although it is much simpler than the NBS and the DS, it still has 11 items to score on and not suitable for use by community birth attendants or Auxiliary Nurse Midwives (ANMs) in India, who deliver newborns at rural health facilities. For these reasons, there is a need of a simple tool for use by ANMs to assess GA at birth and to make appropriate referral decisions \[[@pone.0238315.ref005]--[@pone.0238315.ref007]\]. Considering these implementation gaps, we developed a tablet-based pictorial GA assessment tool, the "Tablet based---Simplified Gestational Age Score" or T-SGAS. T-SGAS was adapted from a previously developed and tested simplified gestational age scoring system \[[@pone.0238315.ref008], [@pone.0238315.ref009]\]. The aim of this study was to assess the accuracy of T-SGAS in assessing prematurity of newborn, over and above birthweight.

Methods {#sec008}
=======

Overall study design {#sec009}
--------------------

This was a cross-sectional validation study to evaluate the accuracy of T-SGAS to ascertain postnatal GA within 24 hours of birth. Details of the methods used have been described elsewhere \[[@pone.0238315.ref008]\]. Briefly, the study was conducted at three second-level care birthing facilities in and around Nagpur in central India. The three study sites in India were: 1) Daga Memorial Women's Hospital, Nagpur, 2) General Hospital, Bhandara and 3) General Hospital, Wardha. These facilities were selected to choose a mixture of rural as well as urban populations, to obtain samples from all GA categories and to get a good representative sample for normal/uncomplicated as well as complicated deliveries. All three hospitals are well equipped for maternal and childcare facilities including labor rooms, caesarean section facility, intensive care units, blood banks and neonatal care units. These facilities serve as district-level referral facilities, providing routine care services under the state public health system.

The mothers of all singleton live births were consented for assessment of the GA of their newborns within 24 hours of birth. Real-time data were collected on tablet-based forms by trained ANMs. T-SGAS is a pictorial App that consisted of photographs that were the best fit for each score of the following four items: newborn's posture (score 0 to +4), skin (score -1 to +5), breast (score -1 to +4) and genitals (score -1 to +4). [Fig 1](#pone.0238315.g001){ref-type="fig"} The T-SGAS app then auto-calculated the total score and classified the newborn's GA category. If the total score was \<14, the newborn was considered \<37 weeks and classified as preterm. The forms also included date of delivery, time of delivery, delivery outcome, gender of newborn and consent status. Another form on the tablet collected data on maternal and newborn demographics, birth weight, LMP, details of USG, and assessment for the study eligibility. This data was collected by an independent data collector from the mother's hospital record.

![Pictorial representation of the neonatal characteristics for the Tablet App for the Simplified Gestational Age Scoring System (T-SGAS).](pone.0238315.g001){#pone.0238315.g001}

Participant selection and recruitment of newborns for the validation of T-SGAS {#sec010}
------------------------------------------------------------------------------

Each facility had a team of 2 ANMs (ANM1 and ANM2) and a data collector working in two, twelve-hour shifts. All mothers above the age of 18 years (legal consenting age), with singleton live births, with a known LMP and with a report of at least one prenatal ultrasound assessment of GA (if more than one, then the earliest ultrasound GA was recorded) gave written informed consent for GA evaluation of their newborn. ANM1 was responsible for this initial screening and consent of the mother. ANM2 was responsible for assessing the same newborn, independently, within 24 hours of birth and after ANM1 had completed and saved her assessment. Once the assessment was completed the data form on the tablet was closed and could not be accessed again. So, ANM1 and ANM2 were blinded to each other's GA assessment scores. Both ANMs were blinded to the neonates\' actual GA based on LMP or USG that was recorded separately by a data collector from the mother's hospital record and the delivery chart. The data collector ascertained the neonate's data eligibility for analysis after the ANMs had finished assessing the neonate. This was done to avoid any possibility of the ANM's knowing the GA of the neonate. Data collection and transmission was on real-time basis to a central data server \[[@pone.0238315.ref008]\].

Statistical analysis {#sec011}
--------------------

Analyses were conducted in Stata 13.1 (Stata Corp, College Station, TX), the R package TREE \[[@pone.0238315.ref010]\] (for classification tree analysis) and the LATENT1 program (Latent1 Software, Version 3, McMaster University, Hamilton, Ontario, Canada, for latent class analyses). Statistical significance was tested at a type I error rate of 0.05. When multiple tests were conducted an appropriate Bonferroni correction \[[@pone.0238315.ref011]\] was applied to adjust the type I error rate to a global value of 0.05. All the analyses were conducted in two subsets of the data: those in whom the LMP and USG estimates of GA were within one week of each other (n = 8,591) and within two weeks of each other (n = 11,305). Agreement between different T-SGAS assessments was analyzed in three steps. Firstly, we used the total T-SGAS scores from the two assessments and estimated Lin's concordance correlation coefficient \[[@pone.0238315.ref012]\] (CCC). Secondly, to test the strength of agreement, as the paired assessments were done by several combinations of ANMs, we used the difference in these two scores to estimate Fleiss's kappa \[[@pone.0238315.ref013]\] to complement the CCC estimates. Thirdly, we used the dichotomous categorizations of preterm obtained from the two assessments and estimated Fleiss's kappa on this dichotomous classification. Our previous studies have shown that a score of 14 or more is indicative of a term baby \[[@pone.0238315.ref009]\]. This cut-off was used to generate the dichotomous categories from the two assessments.

Screening accuracy of the T-SGAS assessments was determined using two complementary approaches. First, a preterm birth was defined when GA at birth was \<37 weeks by the following four reference standard combinations: LMP alone, USG alone, either LMP or USG and both LMP and USG. Using each of these reference standards for classifying a birth as preterm, we first estimated the prevalence of preterm birth and the sensitivity and specificity of T-SGAS assessments. We also determined the predictive accuracy using the area under a receiver operating characteristic (ROC) curve. The ROC curves were based on the predicted probability estimates obtained from logistic regression models. We evaluated the effect of potential confounding on the performance of T-SGAS by the enrolling facility (as a reflection of the influence of prevalence on screening performance), gender of the newborn (since one of the components of T-SGAS is based on the maturity of genitalia) and maternal age (as a reflection of varying likelihood of a preterm birth). Second, since none of these four assessments (ANM1 and ANM2 measurements from T-SGAS and the LMP and USG measurements) can be considered as a 'true' reference standard, we used Walter and Hui's latent class models to estimate the prevalence of a preterm birth and the sensitivity and specificity of the ANM1 and ANM2 assessments.

Classification and regression tree (CART) analysis was used to determine the optimal cut-off for dichotomization of the T-SGAS score which was data-driven from this data set. Birth weight and the T-SGAS assessments were used as predictors in these analysis to identify clinically meaningful risk groups. Also, each of the four aforementioned reference standards (LMP alone, USG alone, either LMP or USG, and, both LMP and USG) was separately considered as the dependent variable and birth weight and total T-SGAS scores were considered as the independent variables. Incremental values of ANM1 and ANM2 assessments over birth weight as a predictor of preterm birth was determined using integrated discrimination improvement (IDI) and net reclassification index (NRI) \[[@pone.0238315.ref014]\].

Ethics statement {#sec012}
----------------

The study protocol and the written informed consent documents were reviewed and approved by the Institutional Review Boards (IRBs) and ethics committees of the Lata Medical Research Foundation IRB (FWA00012971), the Partners Human Research Committee, Boston, MA, and the Boston University Medical Campus IRB.

Results {#sec013}
=======

Study participants {#sec014}
------------------

[Fig 2](#pone.0238315.g002){ref-type="fig"} shows the study flow diagram. Of the 15,920, live births enrolled into the study a total of 8,591 had estimates of GA by LMP and GA by USG within one week of each other and a total of 11,305 (71%) live births had GA by LMP and USG within 2 weeks of each other. Characteristics of the mother and newborn were similar in the included larger (n = 11,305) when compared to the excluded (n = 4,615).The average maternal age of the included live births at conception was 24 years, \~93% of the mothers had received at least a secondary level of education, the average parity was one, and in a majority of cases the mode of delivery was either vaginal or caesarean section. However, the proportion of LBW babies was significantly larger in the excluded babies as compared to the included babies (30.0% versus 18.9%, p \<0.001). The average GA at USG was 32.1±5.9 weeks for the larger dataset and 31.7±6.2 weeks in the subset of 8,591. For simplicity of presentation, henceforth we report the results from the more constrained data set (n = 8,591) as the primary results. Similar analyses (tables and figures) for the full set of 11,305 live births are shown in [S1 Table](#pone.0238315.s005){ref-type="supplementary-material"}.

![SGAS consort diagram showing the population of n = 8591 women with singleton birth included in the analysis.](pone.0238315.g002){#pone.0238315.g002}

Interobserver agreement of T-SGAS scores {#sec015}
----------------------------------------

Using the Lin's concordance correlation coefficient, the agreement in the scores between two assessors (ANMs) was 0.77 (95% CI 0.76--0.78). [Table 1](#pone.0238315.t001){ref-type="table"} shows an excellent agreement among the assessors (Fleiss's kappa = 0.76, 95% CI 0.75--0.78) with 88.3% of the scores were within zero or one point. We also studied the agreements between the assessments (rather than the assessors) classifying as preterm or term, Fleiss's kappa was still high (0.69, 95% CI 0.67--0.70) with 85.5% assessments in complete agreement with each other.

10.1371/journal.pone.0238315.t001

###### Agreement between T-SGAS scores by two assessors (analysis subset: LMP and USG estimates of GA within one week of each other, n = 8,591).

![](pone.0238315.t001){#pone.0238315.t001g}

  Characteristic                  Description
  ------------------------------- -------------------
  Agreement between assessors     
  Complete agreement \[n (%)\]    5,150 (59.9)
  1 point \[n (%)\]               2,438 (28.4)
  2 points \[n (%)\]              703 (8.2)
  3 points \[n (%)\]              199 (2.3)
  4+ points \[n (%)\]             101 (1.2)
  Fleiss's kappa (95% CI)         0.76 (0.75--0.78)
  Agreement between assessments   
  Complete agreement \[n (%)\]    7,349 (85.5)
  Fleiss's kappa (95% CI)         0.69 (0.67--0.70)

Accuracy of the T-SGAS to predict gestational age {#sec016}
-------------------------------------------------

We tested the hypothesis that lower T-SGAS scores are associated with a higher likelihood of a preterm birth. Given the strong agreement between the T-SGAS scores obtained by two assessments, we conducted these analyses using the average T-SGAS score as the predictor variable. Logistic regression analyses using the four reference standards for assessing preterm (based on LMP alone, USG alone, LMP or USG, and LMP and USG) consistently indicated that the probability of a preterm birth was high when scores were below 10, then rapidly declined for scores between 11 and 13 and remained low thereafter ([Fig 3A](#pone.0238315.g003){ref-type="fig"}). ROC curves ([Fig 3B](#pone.0238315.g003){ref-type="fig"}) showed that the predictive accuracy of T-SGAS varied between 74%-- 79% for the four reference standards for assessing GA.

![Accuracy of T-SGAS score to predict gestational age and preterm birth in n = 8,591 participants.](pone.0238315.g003){#pone.0238315.g003}

Risk stratification using birth weight and T-SGAS {#sec017}
-------------------------------------------------

To identify a critical cut-off point of T-SGAS score for identification of a preterm birth, we conducted a series of CART analyses. Results for the first assessor using LMP as a reference standard are shown in [Fig 4](#pone.0238315.g004){ref-type="fig"} and indicated that the overall probability of a preterm birth was \~7%. A combination of birth weight and T-SGAS scores created four groups with widely varying probability profiles. Those with a CART cut-off of birth weight \< 2.575 kg and T-SGAS score \<10 had a 65% probability of preterm birth. Those with birth weight \< 2.575 kg but a T-SGAS score of 11--12 had a 27% probability of preterm birth and those with birth weight \< 2.575 kg but a T-SGAS score of 13 or more had a 9% probability of preterm birth. In contrast, those with a birthweight exceeding 2.575 kg had a probability of preterm birth at 3%. This cut-off of a T-SGAS score of 13 or more as an indicator of a term birth was consistently seen for all the four reference standards ([S1A--S1C Fig](#pone.0238315.s001){ref-type="supplementary-material"}). These analyses were also consistent for the second assessor results. Therefore, for all ensuing analyses we used a T-SGAS score \<13 as indicative of a preterm birth.

![Classification tree analysis for the outcome of LMP in n = 8,591 participants.](pone.0238315.g004){#pone.0238315.g004}

Screening performance of the T-SGAS to identify a preterm birth {#sec018}
---------------------------------------------------------------

Using the cut point of score of 13, we determined the accuracy of T-SGAS to identify a preterm birth. This set of analyses was done in two steps. In the first step, we used each of the four reference standards (LMP alone, USG alone, LMP or USG, LMP and USG) to directly compare the screening performance of both T-SGAS assessments. These results are shown in [Table 2](#pone.0238315.t002){ref-type="table"}. The prevalence of a preterm birth varied between 5.6% to 9.5% based on the reference standard used. Our analyses indicated that irrespective of the reference standard the specificity (ability to detect a 'true' term baby) of T-SGAS score remained high (\~90%). The sensitivity of T-SGAS varied between 40% to 50%. The sensitivity estimates were sensitive to the definition of a preterm birth such that when GA was estimated to be \<37 weeks by both LMP and USG (column titled LMP AND USG in [Table 2](#pone.0238315.t002){ref-type="table"} and [S2 Table](#pone.0238315.s006){ref-type="supplementary-material"}), the sensitivity of T-SGAS score was highest and reached close to 50%. The likelihood ratio of a positive T-SGAS (LR+) remained high, irrespective of the reference standard used or the dataset analyzed, and varied between 3.75--4.88. Similarly, the LR of a negative T-SGAS (LR-) also was consistently observed to be 0.57--0.72. Potential confounding on the performance of T-SGAS by the enrolling facility, gender of the newborn and maternal age had no effect ([S3](#pone.0238315.s007){ref-type="supplementary-material"}, [S4](#pone.0238315.s008){ref-type="supplementary-material"} and [S5](#pone.0238315.s009){ref-type="supplementary-material"} Tables, respectively). This interpretation could be consistently made for all combinations of assessors, reference standards and datasets used for analyses. We then ran latent class analyses for assessing preterm using T-SGAS score, LMP and USG as three independent tests, none of which were considered as a reference standard. Our results ([S6A and S6B Table](#pone.0238315.s010){ref-type="supplementary-material"}) were consistent with the results obtained in the previous step. These results showed that the estimated prevalence of preterm births was \~8%. Also, all three methods have very high specificity (90% or above) but the sensitivity of USG was the highest (above 90%), followed by LMP (\~80%) and then by T-SGAS (\~50%). Using these results, we obtained the estimates of LR of a positive T-SGAS. We found that after accounting for possible classification errors associated with imperfect LMP and USG through latent class analyses, the LR+ of T-SGAS varied between 5.14 to 5.27 (95% CI varying from 4.63--5.85), indicating a strong and significant predictive value of T-SGAS.

10.1371/journal.pone.0238315.t002

###### Screening accuracy of T-SGAS to predict a preterm birth (analysis subset: LMP and USG estimates of GA within one week of each other, n = 8,591).

![](pone.0238315.t002){#pone.0238315.t002g}

  Parameter                   Reference Standard                                                   
  --------------------------- ---------------------- ---------------------- ---------------------- ----------------------
  *Assessor 1*                                                                                     
  Prevalence                  6.83 (6.31--7.39)      8.25 (7.68--8.85)      9.48 (8.86--10.11)     5.61 (5.13--6.12)
  Sensitivity                 43.27 (39.22--47.39)   42.45 (38.78--46.19)   40.05 (36.66--43.51)   47.51 (42.98--52.08)
  Specificity                 90.07 (89.39--90.71)   90.51 (89.84--91.15)   90.70 (90.04--91.34)   89.89 (89.21--90.54)
  Positive Predictive Value   24.21 (21.65--26.92)   28.69 (25.97--31.54)   31.08 (28.29--33.98)   21.83 (19.36--24.46)
  Negative Predictive Value   95.58 (95.10--96.04)   94.59 (94.06--95.09)   93.53 (92.95--94.07)   96.65 (96.21--97.04)
  Likelihood Ratio +          4.36 (3.89--4.88)      4.47 (4.01--4.99)      4.31 (3.86--4.80)      4.70 (4.19--5.27)
  Likelihood Ratio -          0.63 (0.59--0.68)      0.64 (0.60--0.68)      0.66 (0.62--0.70)      0.58 (0.54--0.64)
  *Assessor 2*                                                                                     
  Prevalence                  6.83 (6.31--7.39)      8.25 (7.68--8.85)      9.48 (8.86--10.11)     5.61 (5.13--6.12)
  Sensitivity                 44.63 (40.56--48.76)   41.47 (37.81--45.19)   39.43 (36.06--42.89)   48.76 (44.21--53.32)
  Specificity                 90.22 (89.55--90.86)   90.47 (89.80--91.11)   90.69 (90.02--91.33)   90.01 (89.34--90.66)
  Positive Predictive Value   25.07 (22.47--27.82)   28.13 (25.42--30.97)   30.72 (27.93--33.61)   22.49 (19.99--25.14)
  Negative Predictive Value   95.69 (95.21--96.14)   94.50 (93.96--95.00)   93.47 (92.89--94.01)   96.73 (96.30--97.12)
  Likelihood Ratio +          4.56 (4.08--5.10)      4.35 (3.90--4.86)      4.24 (3.80--4.73)      4.88 (4.36--5.46)
  Likelihood Ratio -          0.61 (0.57--0.66)      0.65 (0.61--0.69)      0.67 (0.63--0.71)      0.57 (0.52--0.62)

Incremental value of T-SGAS over birth weight {#sec019}
---------------------------------------------

We conducted these analyses for both assessors and all four reference standards mentioned earlier. As indicated by the integrated discrimination improvement (IDI) we observed that T-SGAS improved the discrimination by 5--7% irrespective of the assessor. And similarly, the net reclassification index (NRI) estimates demonstrated an improved reclassification when T-SGAS were used in addition to birth weight for classification of live births as preterm. ([S7A and S7B Table](#pone.0238315.s011){ref-type="supplementary-material"})

All of the above described analyses were run on the full set of 11,305 live births and concurring results were obtained which are shown as [S2](#pone.0238315.s006){ref-type="supplementary-material"}--[S9](#pone.0238315.s013){ref-type="supplementary-material"} Tables and [S1](#pone.0238315.s001){ref-type="supplementary-material"}--[S4](#pone.0238315.s004){ref-type="supplementary-material"} Figs.

Discussion {#sec020}
==========

Our main findings were that there was strong agreement between the ANM assessors (concordance correlation coefficient 0.77 (95% CI 0.76--0.78) and Fleiss' kappa was 0.76 (95% CI 0.76--0.78)). The optimal cut-off for the score to predict preterm was 13 and irrespective of the reference standard used (LMP, USG, LMP Or USG, LMP and USG) the specificity of the score was 90% and sensitivity varied from 40--50% and the predictive accuracy between 74%--79% for the reference standards. Latent class models showed similar results indicating no reference standard bias.

A systematic review of 18 newborn assessments for GA estimation (ranging from 4 to 23 signs) concluded that assessments with fewer signs tended to be less accurate. There was a tendency for newborn assessments to overestimate GA in preterm and underestimate GA in growth-restricted infants \[[@pone.0238315.ref015]\]. They recommended that where USG is not available simple yet specific approaches be developed. Our T-SGAS was different from all previously used GA assessments methods that are not only complex but rely on rigorous training of health workers who then have to recall the description of the items to match the score during actual assessments. T-SGAS is simple with just a simple 4 item scoring scale with 3 physical and 1 neurological item. T-SGAS was developed by using the most predictive items from the 12-item New Ballard Score (NBS), 22-item Dubowitz score (DWS) and 11-item Meharban Singh (MS) and validated against the Best obstetrics Estimate (BOE) in low birth weight (LBW) newborns in India \[[@pone.0238315.ref009]\]. Because it showed promising results for estimation of GA in LBW newborn and was easy to by nursing staff in the community it was adapted to a pictorial tablet app (T-SGAS) \[[@pone.0238315.ref008]\]. In the current study the ANMs were trained to use only the T-SGAs and it was validated against the gold standard of GA at birth assessed using prenatal USG, which is also the gold standard for validating any newborn gestational age assessment methods like NBS or DWS. So, validation against NBS or DWS was not considered necessary as any additional training provided to ANMs on NBA or DWS would bias the evaluation skills of ANMs. T-SGAS is unique because it is a pictorial scoring App that contains real life newborn pictures of all the items that match each score. These pictures were obtained from the local preterm population and carefully selected by concurrence between 3 neonatologists to exactly match the description of the scores. The ANMs have to simply select the picture that matches what they observe in the newborn baby. The App then auto-calculates the score and categorizes the newborn as preterm. Therefore, it is not surprising that the assessments were reliable and the concordance between two assessors was high.

The LR+ of T-SGAS was sufficiently high (\~5) to warrant its routine use. Using Pauker-Kassirer approach, we estimated that even if the benefit-to-risk ratio of early detection to a missed diagnosis of a PT birth was as low as 5, the testing threshold to use T-SGAS would be as little as 0.0385. This indicates that if the prevalence of preterm births exceeds 3.85%, there will be a screening value to using the T-SGAS. In developing countries like India, the prevalence of a preterm birth is likely to be high and thus T-SGAS use would be highly relevant in such situations. Furthermore, the benefit-to-risk ratio of early detection of a preterm birth is likely to be much higher in reality, making the routine use of T-SGAS fully justifiable. It is noteworthy that the T-SGAS scores were not significantly influenced by observer variability, maternal age, gender of the newborn and the prevalence differential across enrolling institutions. These observations lend credence to the robustness of T-SGAS.

We noted a relatively low sensitivity (\~50%) of the T-SGAS scores to predict a preterm birth. Of note, sensitivity and specificity--while theoretically independent of the prevalence--may vary with prevalence \[[@pone.0238315.ref016]\]. Also, from a clinical point-of-view, likelihood ratios are superior to sensitivity and specificity by being prevalence-agnostic as well as predictive of the disease condition \[[@pone.0238315.ref017]\]. Our estimates of LR+ for T-SGAS far outweigh the relatively low sensitivity observed in this study. When we aimed to increase the sensitivity by moving the T-SGAS score cut-off, the LR+ estimates were smaller indicating a substantial loss in specificity. For these reasons, we persisted with the cut-off of a total score of 13 as the most discriminatory one.

Conceptually, gestational age--like any age variable--should be measured on the time scale. Thus, use of LMP is a natural choice for GA measurement but the heavy recall bias associated with LMP places demands for alternative measures of GA. USG measures the fetus size and correlates the size with GA, but there are three important constraints for USG use in resource-limited settings: relatively expensive, not always available and inaccurate when USG assessment is done later in pregnancy. As observed in our study ([S2 Fig](#pone.0238315.s002){ref-type="supplementary-material"}), women in developing countries tend to get USG assessments late during pregnancy. Our proposed method (T-SGAS) circumvents these issues associated with LMP and USG and is based on maturity indicators that are simple enough to be identified by an ANM but robust enough to be routinely used.

Two limitations of our study must be recognized. First, this study is of a cross-sectional nature in sub-population of Indian babies from Central India and the prognostic value of the risk groups on neonatal or early childhood outcomes such as morbidity and mortality are unknown. Future studies need to assess the influence of T-SGAS-based risk-stratification on hard clinical endpoints. Second, the primary aim of this study was to validate the accuracy of the T-SGAS score, but prudent ways to combine LMP (when reliable) and USG (when available) need to be devised to further improve the prediction of a preterm birth. Future validation studies from other parts of India are needed before it be recommended for integration into the existing health care services.

Notwithstanding these limitations, our results clearly demonstrate the value of T-SGAS in risk-stratification for identification of preterm births. Interestingly, by redefining the threshold used (37 weeks) in this study, it is conceivable to address other clinically important questions using our tool. For example, if a threshold of 35 weeks is used then the need for admission to a neonatal intensive care unit may also be predicted by this tool. Future studies are needed to directly address such interesting questions. In conclusion, T-SGAS demonstrates strengths of high interobserver agreement, robust and accurate prediction of preterm births, incremental value over birth weight and simplicity of use and interpretation. We advocate strongly in favour of further validation and use of T-SGAS for GA assessment and PT identification, especially in resource-limited scenarios.

To conclude, in the context of preterm births, there exists a significant gap between needs and resources. Developing countries that have among the highest prevalence of preterm births have least availability of the required health facilities for prevention and management of this scourge \[[@pone.0238315.ref018]\]. It is therefore important and imperative to optimize the available resources by adequate risk-stratification. In peripheral settings where expert medical care is not readily available, it is conceivable that local resources like the ANMs can be trained to identify preterm births thereby providing early referral services to the needy. Our results support this contention and indicate that a simple and inexpensive method of GA assessment can be used in the periphery to optimize health resource use for management of a preterm birth.
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The submission titled \"Early identification of preterm neonates at birth with a Tablet App for the Simplified Gestational Age Score (T-SGAS) when ultrasound gestational age dating is unavailable: A validation study\" by Archana Patel et al is an attempt to come up with a screening tool to estimate gestational age of neonates in a resource poor setting so that special attention may be given to infants born \<37 weeks to prevent morbidity and mortality. Authors report on use of a android tablet app by two trained midwife\'s in 4 community hospitals in India to assess gestational age with an aim to designate each infant as either \<37 weeks or \>37 weeks. This tool becomes highly relevant in countries like India where majority of deliveries are conducted by nurse midwife\'s and an assessment of GA helps screen neonates who need special attention and referral to an appropriate tertiary care center. This is a well-designed study and a well-written manuscript and has the potential for widespread use in the third world countries. I would like authors to make several major and minor changes to their submission before it can be considered suitable for publication.
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1\. T-SGAS a pictorial App that consisted of photographs to score four items: newborn's posture (score 0 to +4), skin (score - 134 1 to +5), breast (score -1 to +4) and genitals (score -1 to +4), seems very interesting compared to other established tools like Dubowitz or Modified Ballard. It will be very helpful to our readers if authors could add a figure to the manuscript to depict the images used to do this said scoring. In its current form this manuscript does not provide a visual impression of the assessment being made to our readers.

2\. Was the GA assessment also done by established norms like Dubowitz or Ballard\'s methods by a trained professional? If yes, then how these assessments varied compared to the app? If not then why not? Kindly explain it in the discussion part of the manuscript.

3\. Discussion needs to elaborate on how this tool can be used by ANM\'s and in what way it can be helpful to these designated infants \<37 weeks?

4\. Table 3 and 4 though helpful to a trained professional with good knowledge of biostatistics, does not help our average reader of PLOSone so should be either deleted or published as supplementary tables on the web.

Minor concerns:

1\. Remove repetitive statements in introduction, methods and results to reduce the size of manuscript.

2\. Elaborate on educational status on ANM\'s in your methods section and why they were chosen to do the measurements, were they randomly selected or had special qualifications?
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**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This is a cross-sectional study evaluating the accuracy of Tablet based gestational age estimation app in low resource setting. They have identified score \<14 as good predictor of identifying preterm birth (\<37 weeks) and 9% probability of preterm birth if score\>13 and weight \<2.5kg.

The app has high Inter & intra-observer variation and Likelihood ratio, though sensitivity is low. The study is well designed and the analysis is robust and potential for being a useful tool in low-resource settings.

Concerns:

1\. 37 weeks was used as the cutoff for identifying preterm birth or not. How valid is the tool at other gestational ages - \<32 weeks, \<35 weeks etc. \<37 weeks is important for epidemiological reasons to identify preterm birth. However, infants \>35 weeks generally don't require admission to NICU. This data would be more helpful for clinicians whether the baby needs to be transported to the NICU or not, which in a low resource NICU could be a significant cost.

2\. Can you clarify if the ANM assessor's correlation coefficient was for assessors from all three study sites?

3\. Likelihood ratios should be included in the abstract.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Please include the following items when submitting your revised manuscript:

• A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.

• A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.

• An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

RESPONSE TO REVIEWER

Additional Editor Comments (if provided):

The submission titled \"Early identification of preterm neonates at birth with a Tablet App for the Simplified Gestational Age Score (T-SGAS) when ultrasound gestational age dating is unavailable: A validation study\" by Archana Patel et al is an attempt to come up with a screening tool to estimate gestational age of neonates in a resource poor setting so that special attention may be given to infants born \<37 weeks to prevent morbidity and mortality. Authors report on use of a android tablet app by two trained midwife\'s in 4 community hospitals in India to assess gestational age with an aim to designate each infant as either \<37 weeks or \>37 weeks. This tool becomes highly relevant in countries like India where majority of deliveries are conducted by nurse midwife\'s and an assessment of GA helps screen neonates who need special attention and referral to an appropriate tertiary care centre. This is a well-designed study and a well-written manuscript and has the potential for widespread use in the third world countries. I would like authors to make several major and minor changes to their submission before it can be considered suitable for publication.

Response: We are thankful to you for careful review and understanding the relevance of this paper in India.

Major concerns:

1\. T-SGAS a pictorial App that consisted of photographs to score four items: newborn's posture (score 0 to +4), skin (score - 134 1 to +5), breast (score -1 to +4) and genitals (score -1 to +4), seems very interesting compared to other established tools like Dubowitz or Modified Ballard. It will be very helpful to our readers if authors could add a figure to the manuscript to depict the images used to do this said scoring. In its current form this manuscript does not provide a visual impression of the assessment being made to our readers.

Response:

1\. We have added the visual impression of the T-SGAS in the manuscript's method section as figure 1. In our earlier referenced paper - "Patel A, Kurhe K, Prakash A, Bhargav S, Parepalli S, Fogleman E et al. Development and Validation of a Tablet-based Simplified Gestational Age Score (T-SGAS) for Early Identification of Preterm Neonates at Birth when Ultrasound Gestational Age Dating is Not Available: A Global Network for Maternal and Child Health Research Protocol. Available at: <http://preprints.jmir.org/preprint/11913> DOI: 10.2196/preprints.11913." we have described in detail how this simplified score was adapted with pictures on a tablet.

2\. Was the GA assessment also done by established norms like Dubowitz or Ballard\'s methods by a trained professional? If yes, then how these assessments varied compared to the app? If not then why not? Kindly explain it in the discussion part of the manuscript.

Response:

The Simplified Gestational Age Score development on the tablet underwent the following two steps --

Step - 1) We evaluated the 12-item New Ballard Score (NBS), 22-item Dubowitz score (DWS) and 11-item Meharban Singh (MS) and assessed the correlation of the total of these 3 scores and each item in these 3 scores with the Best obstetrics Estimate (BOE) (LMP and USG as gold standard). (Ref. Patel A, Lothe A, Belekar N, Thakur H. Development and initial validation of a simplified gestational age score in low birth weight newborns in India. Indian Journal of Child Health 2017;5(1): 15-19.) Through this exercise, we developed a 4-item simplified gestational age score (SGAS) for use in low birth weight newborns in India. SGAS showed promising results for accurate estimation of GA in LBW newborn and ease of use by nursing staff in the community.

Step -- 2) We adapted the 4-item simplified gestational age score (SGAS) to a pictorial tablet app. This method was described in our referenced paper - "Patel A, Kurhe K, Prakash A, Bhargav S, Parepalli S, Fogleman E et al. Development and Validation of a Tablet-based Simplified Gestational Age Score (T-SGAS) for Early Identification of Preterm Neonates at Birth when Ultrasound Gestational Age Dating is Not Available: A Global Network for Maternal and Child Health Research Protocol. Available at: <http://preprints.jmir.org/preprint/11913> DOI: 10.2196/preprints.11913."

In the current study the ANMs were trained to use only the T-SGAs. The aim of this study was to assess if ANMs who otherwise have minimal training in assessment of gestational age are able to use the T-SGAS reliably to assess GA of newborns at birth. It was validated against the gold standard of GA at birth assessed using prenatal USG, which is also the gold standard for validating any newborn gestatational age assessment methods like NBS or any other scoring method. So validation against NBS or DWS was not considered for two reasons -- 1) Any neonatal GA assessment score is a less accurate method for assessment of GA than prenatal USG, 2) Any additional training provided to ANMs on NBA or DWS would bias the evaluation skills of ANMs.

This has now been explained in the discussion section.

3\. Discussion needs to elaborate on how this tool can be used by ANM\'s and in what way it can be helpful to these designated infants \<37 weeks?

Response:

We have explained in the methods and discussion section that the ANM has to simply select the picture on the Tablet App that matches the what they observed in the newborn baby. The App then auto-calculated the score which categorizes the newborn as preterm \< 37 weeks. The T-SGAS had high reliability and high enough likelihood ratios to warrant its routine use by ANMs to refer preterm newborns to higher facilties.

4\. Table 3 and 4 though helpful to a trained professional with good knowledge of biostatistics, does not help our average reader of PLOSone so should be either deleted or published as supplementary tables on the web.

Response:

We have now moved table 3 and 4 to supplement. It is now S6a and S7a respectively

Minor concerns:

1\. Remove repetitive statements in introduction, methods and results to reduce the size of manuscript.

Response:

We have done as suggested.

2\. Elaborate on educational status on ANM\'s in your methods section and why they were chosen to do the measurements, were they randomly selected or had special qualifications?

Response:

The educational level of ANMs is a diploma in midwifery of 2 years provided after high school education. The reason behind selecting, ANM's for this study was that they provide midwifery service at all rural primary health centers. They were selected on random basis and trained in use of the T-SGAS App

Journal requirements:

When submitting your revision, we need you to address these additional requirements:

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at <http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf> and <http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

Response:

We have done the needful.

2\. Please provide additional details regarding participant consent. In the Methods section, please ensure that you have specified what type of consent you obtained (for instance, written or verbal) and whether the ethics committee approved this consent procedure. If verbal consent was obtained please state why it was not possible to obtain written consent and how verbal consent was recorded. If your study included minors, state whether you obtained consent from parents or guardians.

Response:

We have now provided the details in the methods section.

3\. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to 'Update my Information' (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: <https://www.youtube.com/watch?v=_xcclfuvtxQ>

Response:

ORCID iD-0000-0002-25587421 (Dr. Archana Patel) It has been validated in the editorial manager.

4\. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see <http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions>.

Response:

Indian Council of Medical Research does not allow data sharing unless the protocol for data sharing was previously approved by them, the Institutional Ethics Committee and consented by the participants. If data is requested by the journal for verification of results we will seek permissions from the Institutional Ethics Committee (LMRF-IEC), our Sponsors and the Indian Council of Medical Research.

Contact details for LMRF-IEC:

Dr. Prabir Kumar Das, Member Secretary

Email ID- <prabir_das23@rediffmail.com>

However, other researchers may submit data access requests to Dr. Prabir Kumar Das, Member Secretary at LMRF-IEC (<prabir_das23@rediffmail.com>)."

In your revised cover letter, please address the following prompts:

a\) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

Response:

Please see our response above. The contact information for data access our --

LMRF-IEC:

Dr. Prabir Kumar Das

Member Secretary

Lata Medical Research Foundation,

Kinkini Kutir, Vasantnagar, Nagpur -- 440022

Ph. No. 91-8805023450

Email.ID- <prabir_das23@rediffmail.com>

b\) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see <http://www.bmj.com/content/340/bmj.c181.long> for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see <http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories>.

Response:

Please see previous response.

5\. Thank you for stating the following in the Competing Interests section:

\"The authors declare no competing interests.\"

We note that one or more of the authors are employed by a commercial company: M&H Research, LLC

1\. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors\' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Response:

While Dr. Kulkarni is affiliated to M&H Research, LLC, San Antonio, TX, USA; this work was done under the aegis of Lata Medical Research Foundation, Nagpur, India of which Dr. Kulkarni is the President and provides his services gratis. No funding was received from M&H Research, LLC for work reported here.

Please also include the following statement within your amended Funding Statement.

"The funder provided support to the institute for conduct of the study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

Response:

The commercial affiliation had no role to play in our study.

2\. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: \"This does not alter our adherence to PLOS ONE policies on sharing data and materials." (as detailed online in our guide for authors <http://journals.plos.org/plosone/s/competing-interests>) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: <http://journals.plos.org/plosone/s/competing-interests>

6\. We note that you have included the phrase "data not shown" in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

Response:

We have provided an explanation regarding the data sharing requirement. We shall remove the phrase.

7\. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.
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Response:

This has now been provided.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

Comments to the Author

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

3\. Have the authors made all data underlying the findings in their manuscript fully available?
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